Advertisement
Singapore markets close in 6 hours 40 minutes
  • Straits Times Index

    3,267.71
    -25.42 (-0.77%)
     
  • Nikkei

    37,762.67
    -697.41 (-1.81%)
     
  • Hang Seng

    17,289.52
    +88.25 (+0.51%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,262.36
    -2,401.43 (-3.60%)
     
  • CMC Crypto 200

    1,383.93
    -40.17 (-2.82%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,331.40
    -7.00 (-0.30%)
     
  • Crude Oil

    82.73
    -0.08 (-0.10%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,572.00
    +0.52 (+0.03%)
     
  • Jakarta Composite Index

    7,153.51
    -21.02 (-0.29%)
     
  • PSE Index

    6,589.89
    +17.14 (+0.26%)
     

SAGE Therapeutics’ Strategic Collaboration with Shionogi

SAGE Therapeutics’ Strategic Collaboration with Shionogi

On June 13, SAGE Therapeutics (SAGE) announced a strategic collaboration with Shionogi & Company for the development and commercialization of the drug SAGE-217. Let’s take a look at the details of the collaboration.